1. Home
  2. INZY vs CSPI Comparison

INZY vs CSPI Comparison

Compare INZY & CSPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • CSPI
  • Stock Information
  • Founded
  • INZY 2015
  • CSPI 1968
  • Country
  • INZY United States
  • CSPI United States
  • Employees
  • INZY N/A
  • CSPI N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • CSPI EDP Services
  • Sector
  • INZY Health Care
  • CSPI Technology
  • Exchange
  • INZY Nasdaq
  • CSPI Nasdaq
  • Market Cap
  • INZY 256.3M
  • CSPI 105.9M
  • IPO Year
  • INZY 2020
  • CSPI 1987
  • Fundamental
  • Price
  • INZY N/A
  • CSPI $12.84
  • Analyst Decision
  • INZY Buy
  • CSPI
  • Analyst Count
  • INZY 9
  • CSPI 0
  • Target Price
  • INZY $15.22
  • CSPI N/A
  • AVG Volume (30 Days)
  • INZY 989.2K
  • CSPI 78.7K
  • Earning Date
  • INZY 08-05-2025
  • CSPI 08-12-2025
  • Dividend Yield
  • INZY N/A
  • CSPI 0.93%
  • EPS Growth
  • INZY N/A
  • CSPI N/A
  • EPS
  • INZY N/A
  • CSPI N/A
  • Revenue
  • INZY N/A
  • CSPI $54,955,000.00
  • Revenue This Year
  • INZY N/A
  • CSPI N/A
  • Revenue Next Year
  • INZY N/A
  • CSPI N/A
  • P/E Ratio
  • INZY N/A
  • CSPI N/A
  • Revenue Growth
  • INZY N/A
  • CSPI N/A
  • 52 Week Low
  • INZY $0.72
  • CSPI $10.39
  • 52 Week High
  • INZY $6.24
  • CSPI $21.95
  • Technical
  • Relative Strength Index (RSI)
  • INZY 82.67
  • CSPI 51.81
  • Support Level
  • INZY $3.94
  • CSPI $11.84
  • Resistance Level
  • INZY $3.97
  • CSPI $13.24
  • Average True Range (ATR)
  • INZY 0.01
  • CSPI 0.72
  • MACD
  • INZY -0.08
  • CSPI 0.27
  • Stochastic Oscillator
  • INZY 100.00
  • CSPI 85.96

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About CSPI CSP Inc.

CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.

Share on Social Networks: